{"id":"crmd-001-deferiprone","safety":{"commonSideEffects":[{"rate":"30%","effect":"Gastrointestinal disturbances"},{"rate":"10%","effect":"Hepatotoxicity"},{"rate":"5%","effect":"Neutropenia"}]},"_chembl":{"chemblId":"CHEMBL70927","moleculeType":"Small molecule","molecularWeight":"139.15"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Deferiprone is a small molecule that chelates iron, reducing its accumulation in tissues and mitigating oxidative stress.","oneSentence":"Iron chelator","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:29:35.405Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Beta-thalassemia major"},{"name":"Sickle cell disease"}]},"trialDetails":[{"nctId":"NCT01391520","phase":"PHASE3","title":"Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent","status":"WITHDRAWN","sponsor":"CorMedix","startDate":"2012-01","conditions":"Acute Kidney Injury","enrollment":""},{"nctId":"NCT01146925","phase":"PHASE2","title":"Deferiprone for the Prevention of Contrast-Induced Acute Kidney Injury","status":"COMPLETED","sponsor":"CorMedix","startDate":"2010-06","conditions":"Contrast-Induced Acute Kidney Injury","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CRMD-001-Deferiprone","genericName":"CRMD-001-Deferiprone","companyName":"CorMedix","companyId":"cormedix","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron chelator Used for Beta-thalassemia major, Sickle cell disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}